E1 ReplicatedModerate confidencePEM unclearRCTPeer-reviewedMachine draft
Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy.
Williams, G, Waterhouse, J, Mugarza, J et al. · European journal of clinical investigation · 2002 · DOI
Quick Summary
This study tested whether melatonin pills and bright light therapy could help ME/CFS patients feel better. Thirty patients tried both treatments (and a placebo) for 12 weeks each. Neither treatment improved fatigue, physical health, mental health, or mood compared to placebo, even though both are sometimes recommended for ME/CFS.
Why It Matters
Many ME/CFS patients are offered melatonin and light therapy by practitioners based on the theory that circadian disruption drives symptoms. This high-quality RCT provides evidence that these widely-prescribed interventions do not benefit ME/CFS patients, helping prevent unnecessary or ineffective treatment and redirecting research toward more promising therapeutic targets.
Observed Findings
- Melatonin and phototherapy showed no significant effect on any principal CFS symptoms compared to placebo.
- Neither treatment significantly altered body temperature rhythm or melatonin secretion onset, except for a small 0.8-hour phase advance with phototherapy (P = 0.04).
- Patient-reported physical and mental health measures (SF-36, Mental Fatigue Inventory, Hospital Anxiety and Depression Scale) showed no significant improvement with either intervention.
- Both treatments were tolerated without reported serious adverse events during the 12-week periods.
Inferred Conclusions
- Melatonin and bright-light phototherapy are ineffective treatments for CFS symptoms and do not normalize circadian parameters in this patient population.
- The unregulated prescription of these treatments for CFS sufferers by medical and alternative practitioners should be reconsidered pending stronger evidence of efficacy.
- Circadian rhythm correction alone may not be a sufficient therapeutic approach for CFS, suggesting alternative or additional pathophysiological mechanisms require investigation.
Remaining Questions
- Do ME/CFS patients with documented severe circadian phase disorders or inverted rhythms show better response to these interventions than an unselected CFS population?
- Are there patient subgroups defined by baseline circadian characteristics (e.g., severity of desynchronization, amplitude of rhythm) that might respond differently to melatonin or phototherapy?
What This Study Does Not Prove
This study does not prove that circadian rhythm disturbances do not occur in ME/CFS, only that correcting them with melatonin or phototherapy does not improve symptoms. It also does not rule out the possibility that subgroups of patients with specific circadian profiles might benefit, nor does it exclude the potential value of other circadian interventions not tested here.
Tags
Symptom:Unrefreshing SleepFatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall Sample
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →